Haruo Sugano

Title: Haruo Sugano: Innovator in Interleukin-2 Research

Introduction

Haruo Sugano is a notable inventor based in Tokyo, Pennsylvania, known for his significant contributions to the field of biotechnology. His work primarily focuses on the development of interleukin-2 polypeptides, which play a crucial role in immune response.

Latest Patents

Sugano holds a patent for recombinantly produced interleukin-2, which exhibits human IL-2 activity. This innovative polypeptide has a molecular weight of approximately 15,000 daltons and demonstrates stability across a pH range of 2-9. Additionally, it is resistant to elevated temperatures. The recombinant IL-2 is essential for promoting the proliferation of cytotoxic T lymphocytes, making it a vital component in cancer research and immunotherapy.

Career Highlights

Throughout his career, Sugano has worked with prominent organizations, including Ajinomoto Co., Ltd. and the Japanese Foundation for Cancer Research. His expertise in biotechnology and immunology has positioned him as a key figure in the advancement of therapeutic applications of interleukin-2.

Collaborations

Sugano has collaborated with esteemed colleagues such as Tadatsugu Taniguchi and Masami Muramatsu, further enhancing the impact of his research in the scientific community.

Conclusion

Haruo Sugano's innovative work in the field of interleukin-2 research has made significant strides in biotechnology and immunotherapy. His contributions continue to influence the development of treatments for various diseases, particularly in cancer therapy.